Avanos Medical, Inc.
AVNS
$11.36
-$0.07-0.61%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,263.64% | 101.66% | -9,339.53% | 138.89% | 300.00% |
| Total Depreciation and Amortization | 4.17% | -13.51% | -5.13% | 3.54% | -0.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,860.98% | -98.97% | 11,993.94% | -48.44% | 82.86% |
| Change in Net Operating Assets | -225.93% | -88.00% | 1,116.22% | -55.42% | 137.73% |
| Cash from Operations | -73.54% | -55.61% | 151.74% | -17.27% | 447.50% |
| Capital Expenditure | -64.18% | -39.58% | -60.00% | 49.15% | -43.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | 200.00% | -200.00% |
| Other Investing Activities | 8.33% | 14.29% | 74.77% | -628.57% | -- |
| Cash from Investing | -45.05% | -19.74% | 36.67% | -103.39% | -195.00% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 91.21% | 0.00% | -106.82% | -780.00% | 87.07% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | 63.64% | -2,100.00% | 0.00% | 97.14% | 61.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | 89.00% | -6.20% | -71.25% | -220.00% | -614.29% |
| Foreign Exchange rate Adjustments | 61.11% | 142.86% | -333.33% | 460.00% | 58.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.38% | -157.22% | 684.38% | -119.51% | 237.82% |